FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4408111000001102: Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21580701000001117 Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60246401000001114 Quinupristin 150mg / Dalfopristin 350mg powder for solution for infusion vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Is pack of Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has active ingredient Quinupristin false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has active ingredient Dalfopristin false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has active ingredient Dalfopristin mesilate false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has active ingredient Quinupristin mesilate false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has active ingredient Dalfopristin mesilate false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has VMP Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quinupristin true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dalfopristin true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has specific active ingredient Dalfopristin mesilate true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has specific active ingredient Quinupristin mesilate true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has basis of strength substance Quinupristin true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has basis of strength substance Dalfopristin true Inferred relationship Existential restriction modifier
Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synercid powder for solution for injection vials (Aventis Pharma) 1 vial Is a True Dalfopristin 350mg / Quinupristin 150mg powder for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start